Bimatoprost, prostamide activity, and conventional drainage. - Wikidata - awgldk - TriplyDB

Bimatoprost, prostamide activity, and conventional drainage.

Bimatoprost, prostamide activity, and conventional drainage.

http://www.wikidata.org/entity/Q37187695

about

Molecular characterization of a novel type of prostamide/prostaglandin F synthase, belonging to the thioredoxin-like superfamily Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes Current understanding of conventional outflow dysfunction in glaucoma Prostanoid receptor antagonists: development strategies and therapeutic applications Recent advances in pharmacotherapy of glaucoma Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of Latanoprost.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension Effects of prostaglandin analogues on aqueous humor outflow pathways.Endothelin antagonism as an active principle for glaucoma therapy Prostamides (prostaglandin-ethanolamides) and their pharmacology.Clinical options for the reduction of elevated intraocular pressure Cellular basis for bimatoprost effects on human conventional outflow.Aqueous humor outflow: dynamics and disease.Outflow facility efficacy of five drugs in enucleated porcine eyes by a method of constant-pressure perfusion.Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow Pathways Differential effects of prostaglandin E2-sensitive receptors on contractility of human ocular cells that regulate conventional outflow Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility.Bimatoprost - a review.Efficacy and safety of bimatoprost in glaucoma and ocular hypertension in non-responder patients.Unconventional aqueous humor outflow: A review.Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors.The many faces of the trabecular meshwork cell.Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% - an observational switch study.The biodisposition and hypertrichotic effects of bimatoprost in mouse skin Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides.Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X.Biomechanical, ultrastructural, and electrophysiological characterization of the non-human primate experimental glaucoma model.Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway.PHARMACOLOGICAL REGULATION OF OUTFLOW RESISTANCE DISTAL TO SCHLEMM'S CANAL.

P2860

Q24300569-964E9165-7E1B-4FE4-996B-3865C81E4510 Q24336682-28DB6DA1-3438-4EEB-9994-5FC1762E8C65 Q26991731-2787A738-03A5-4ACB-B512-0AAFA1D0AE38 Q33485483-0F529603-9A0D-4AE7-82DD-5777051F2F33 Q33521178-4AACA7BA-ECAE-4D61-9671-D000463DE996 Q33727601-8EE95963-1BBB-4092-B7FE-6873FFA88665 Q34043309-D5DEABD9-2A5C-49E1-99E2-38C5EAA37BB3 Q34393424-7850726C-6F97-48FE-AE5D-029311BCF0D1 Q34588644-21BE95CE-A2DE-470F-8221-CC31F0C112BD Q34667670-98F78B0C-23AC-425F-92EC-327E81E57BA3 Q34708267-F7EF13C7-5C94-40DF-8AFB-D3278227FB3B Q34735244-3919E279-B4A1-493E-9044-223C20B43470 Q35608780-717D0E49-B4CA-4AE9-A761-5FC8C337193A Q35870708-3C157637-5A4E-4E68-B21A-E5D2FB89CB15 Q35969296-682F306F-4FD6-4B92-B33B-BF1652458C5B Q37035691-4D3AC0A5-7D0C-4B36-BBF6-C32AFE278973 Q37336299-E619B78D-4B7F-46FA-A9B3-82AD3CBE1D84 Q37452805-C6BC3F98-E9D5-4451-BDBB-58BC7ADD3DE5 Q37623833-DB63EEA8-9CA4-44BF-9A33-7371B52B3D6D Q38598695-2E408A8A-7932-4BC2-BF6F-A55E8754D242 Q38724447-B4921CE1-1657-41B3-8E5C-46BEFC717714 Q38725839-517FDDE6-3DC0-442B-A172-4EC31F20E8ED Q38904598-ABC5301F-FDF8-45A6-8843-269EE184BABF Q41200583-7A839B6D-F329-4464-8723-47DABF5ED5E1 Q41250376-3460DA90-B225-43A2-85E2-011FE558F1FC Q42943389-6BFD997A-2437-4157-B1A3-F50BB1EDB8B0 Q43225993-699567BA-587F-42B7-9350-0779A06D8717 Q44977209-0A6954E8-2B09-4830-B312-FB46C08D6ECA Q45872509-ED8DEC8A-7441-49EB-8814-74F6548F2BF0 Q52598356-2C890774-5B11-483E-9F51-1D12BEBD914E

P2860

Bimatoprost, prostamide activity, and conventional drainage.

http://www.wikidata.org/entity/Q37187695

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bimatoprost, prostamide activity, and conventional drainage.

@en

Bimatoprost, prostamide activity, and conventional drainage.

@nl

type

label

Bimatoprost, prostamide activity, and conventional drainage.

@en

Bimatoprost, prostamide activity, and conventional drainage.

@nl

prefLabel

Bimatoprost, prostamide activity, and conventional drainage.

@en

Bimatoprost, prostamide activity, and conventional drainage.

@nl

P1433

Q37187695-7EFA13D5-0DE6-44C7-9E1E-91D2DAAE185D

P1476

Q37187695-F171C2FC-0841-477F-95C5-600BE8914A19

P2093

Q37187695-0DA3330C-7EEB-439E-AD42-88BA81A5D411

Q37187695-10860892-E8B0-460A-866F-8F23A5129F1E

Q37187695-204BD5B0-17CE-4AD5-B6B1-7F1FE7CD8B51

Q37187695-31AEE13D-1169-477B-932C-D51A12554C72

Q37187695-35149A33-CCE6-4D27-8144-AE693E99BB34

Q37187695-54E5867F-EFD1-4429-93D5-AF3075DFAED0

Q37187695-58F89930-E7D3-4934-A7B7-88A1E94613F7

Q37187695-5BDD9D54-E48F-4DA8-BE2D-E3EF5BF0D1BF

Q37187695-6912B64E-25D7-4D8F-87FE-422FAFFC7798

Q37187695-6F3FE146-86FA-48E3-9832-67F417BF40FD

P2860

Q37187695-08C645C6-3E43-40DF-B4CD-83A97B09C207

Q37187695-18C8C62F-8A58-49B4-8095-D451E844A746

Q37187695-20B6D4FF-CE12-4F53-976B-2F7E3C221329

Q37187695-3844966A-B10D-4023-B824-C17B69888F57

Q37187695-3B5986CE-F238-41CF-B785-759907648A34

Q37187695-3BBE6E06-79C5-430D-9546-639C12888F5C

Q37187695-3C23A4C1-7A8E-4030-9AA4-4A5AF655DEB5

Q37187695-3F084244-D6C6-4602-8292-980EE8D745A9

Q37187695-4334889C-210B-4FDD-AC36-E63FCB83C178

Q37187695-44047CEB-54CF-4D3B-AD79-494ABA18CACE

P304

Q37187695-9856D5BE-C227-4474-95FD-898B27EB7170

P31

Q37187695-0303E3D4-0DBD-40B6-A3F7-C0C94F592D5E

P356

Q37187695-C8E1CB9A-B2A3-46D1-8062-E69D4E58BE29

P407

Q37187695-07020692-1F33-4BCF-BE2B-21A69320DBE6

P433

Q37187695-2BBB15B7-A784-459F-8F76-8EA4CB0DB56C

P478

Q37187695-9D9711E0-A645-4523-897F-6FF3FBF7EE9C

P577

Q37187695-17F35BD3-7F05-4E09-A367-EBEEC2BDBBF0

P5875

Q37187695-0CA17183-D04F-40B9-A91F-289B0F395225

P698

Q37187695-18D8969C-498C-41B4-8106-53AAEFC9ECF2

P932

Q37187695-2B88DD08-7758-47AB-9B20-3DD6EC897A4F

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Bimatoprost, prostamide activity, and conventional drainage.

@en

P2093

Alexander B Kharlamb

http://www.w3.org/2001/XMLSchema#string

Clive L Cornell

http://www.w3.org/2001/XMLSchema#string

Craig S Struble

http://www.w3.org/2001/XMLSchema#string

David F Woodward

http://www.w3.org/2001/XMLSchema#string

Hans G Fliri

http://www.w3.org/2001/XMLSchema#string

Jenny W Wang

http://www.w3.org/2001/XMLSchema#string

José L Martos

http://www.w3.org/2001/XMLSchema#string

Kari J Landsverk

http://www.w3.org/2001/XMLSchema#string

Larry A Wheeler

http://www.w3.org/2001/XMLSchema#string

Michael E Garst

http://www.w3.org/2001/XMLSchema#string

P2860

Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds

The pharmacology of bimatoprost (Lumigan).

Isolation, culture, and characterization of endothelial cells from Schlemm's canal.

Measurement of uveoscleral outflow in humans.

Effects of prostaglandins on the aqueous humor outflow pathways.

Studies using isolated uterine and other preparations show bimatoprost and prostanoid FP agonists have different activity profiles.

Update on prostaglandin analogs.

Bimatoprost: a novel antiglaucoma agent.

Understanding mechanisms of pressure-induced optic nerve damage.

Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease.

P304

4107-4115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.07-0080

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6116508

http://www.w3.org/2001/XMLSchema#string

P698

17724194

http://www.w3.org/2001/XMLSchema#string

P932

2680422

http://www.w3.org/2001/XMLSchema#string